Capital World Investors
MCRB icon

Capital World Investors’s Seres Therapeutics MCRB Stock Holding History

Capital World Investors’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-41,391
Closed -$6.08M – 551
2018
Q1 		$6.08M Sell
41,391
-10,600
-20% -$2.03M ﹤0.01% 494
2017
Q4 		$10.5M Sell
51,991
-20,325
-28% -$4.18M ﹤0.01% 467
2017
Q3 		$23.2M Sell
72,316
-5,734
-7% -$1.57M 0.01% 413
2017
Q2 		$17.6M Hold
78,050
– – ﹤0.01% 433
2017
Q1 		$17.6M Hold
78,050
– – ﹤0.01% 430
2016
Q4 		$15.5M Buy
78,050
+11,200
+17% +$2.44M ﹤0.01% 417
2016
Q3 		$16.4M Buy
66,850
+49,225
+279% +$17.3M ﹤0.01% 419
2016
Q2 		$10.2M Hold
17,625
– – ﹤0.01% 441
2016
Q1 		$9.36M Hold
17,625
– – ﹤0.01% 448
2015
Q4 		$12.4M Buy
17,625
+3,250
+23% +$2.14M ﹤0.01% 455
2015
Q3 		$8.52M Sell
14,375
-4,375
-23% -$3.57M ﹤0.01% 482
2015
Q2 		$15.6M Buy
+18,750
New +$16.4M ﹤0.01% 460

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Capital World Investors's MCRB Position: Q2 2018 in Review

Capital World Investors sold out of Seres Therapeutics (MCRB) in Q2 2018, closing a stake of 41,391 shares — an estimated $6.08M sold.

Capital World Investors first reported a position in MCRB in Q2 2015 and held it in 12 quarters. The position peaked at $23.2M in Q3 2017. 78 funds tracked by Wall St. Rank hold MCRB as of Q2 2018.

  • Capital World Investors reported no remaining Seres Therapeutics position as of Q2 2018 after selling out during the quarter.
  • Capital World Investors sold 41,391 Seres Therapeutics shares in Q2 2018, an estimated $6.08M.
  • Capital World Investors first reported a position in Seres Therapeutics in Q2 2015 and held it in 12 quarters.
  • Capital World Investors's Seres Therapeutics position peaked at $23.2M in Q3 2017.
  • 78 funds tracked by Wall St. Rank held Seres Therapeutics as of Q2 2018.

Based on Capital World Investors's 13F filing for Q2 2018, filed 14 Aug 2018.